Chiahao Lu1, Kenneth H Louie2, Emily L Twedell3, Jerrold L Vitek4, Colum D MacKinnon4, Scott E Cooper4. 1. Department of Neurology, University of Minnesota, 516 Delaware Street SE, Minneapolis, MN 55455, United States. Electronic address: luxxx214@umn.edu. 2. Department of Biomedical Engineering, University of Minnesota, 7-105 Hasselmo Hall, 312 Church Street SE, Minneapolis, MN 55455, United States; Department of Neurological Surgery, University of California, 521 Parnassus Ave, M779, San Francisco, CA 94143, United States. 3. Department of Neurology, University of Minnesota, 516 Delaware Street SE, Minneapolis, MN 55455, United States; Department of Neuroscience, University of California, 495 Nelson Rising Lane, San Francisco, CA 94158, United States. 4. Department of Neurology, University of Minnesota, 516 Delaware Street SE, Minneapolis, MN 55455, United States.
Abstract
BACKGROUND: Treadmills provide a safe and convenient way to study the gait of people with Parkinson's disease (PD), but outcome measures derived from treadmill gait may differ from overground walking. OBJECTIVE: To investigate how the relationships between gait metrics and walking speed vary between overground and treadmill walking in people with PD and healthy controls. METHODS: We compared 29 healthy controls to 27 people with PD in the OFF-medication state. Subjects first walked overground on an instrumented gait walkway, then on an instrumented treadmill at 85%, 100% and 115% of their overground walking speed. Average stride length and cadence were computed for each subject in both overground and treadmill walking. RESULTS: Stride length and cadence both differed between overground and treadmill walking. Regressions of stride length and cadence on gait speed showed a log-log relationship for both overground and treadmill gait in both PD and control groups. The difference between the PD and control groups during overground gait was maintained for treadmill gait, not only when treadmill speed matched overground speed, but also with ± 15% variation in treadmill speed from that value. SIGNIFICANCE: These results show that the impact of PD on stride length and cadence and their relationship to gait speed is preserved in treadmill as compared to overground walking. We conclude that a treadmill protocol is suitable for laboratory use in studies of PD gait therapeutics.
BACKGROUND: Treadmills provide a safe and convenient way to study the gait of people with Parkinson's disease (PD), but outcome measures derived from treadmill gait may differ from overground walking. OBJECTIVE: To investigate how the relationships between gait metrics and walking speed vary between overground and treadmill walking in people with PD and healthy controls. METHODS: We compared 29 healthy controls to 27 people with PD in the OFF-medication state. Subjects first walked overground on an instrumented gait walkway, then on an instrumented treadmill at 85%, 100% and 115% of their overground walking speed. Average stride length and cadence were computed for each subject in both overground and treadmill walking. RESULTS: Stride length and cadence both differed between overground and treadmill walking. Regressions of stride length and cadence on gait speed showed a log-log relationship for both overground and treadmill gait in both PD and control groups. The difference between the PD and control groups during overground gait was maintained for treadmill gait, not only when treadmill speed matched overground speed, but also with ± 15% variation in treadmill speed from that value. SIGNIFICANCE: These results show that the impact of PD on stride length and cadence and their relationship to gait speed is preserved in treadmill as compared to overground walking. We conclude that a treadmill protocol is suitable for laboratory use in studies of PD gait therapeutics.
Authors: A Williams Andrews; Susan A Chinworth; Michael Bourassa; Miranda Garvin; Dacia Benton; Scott Tanner Journal: J Geriatr Phys Ther Date: 2010 Jul-Sep Impact factor: 3.381
Authors: Patrick O Riley; Gabriele Paolini; Ugo Della Croce; Kate W Paylo; D Casey Kerrigan Journal: Gait Posture Date: 2006-08-14 Impact factor: 2.840
Authors: Tom J W Buurke; Claudine J C Lamoth; Lucas H V van der Woude; Rob den Otter Journal: IEEE Trans Neural Syst Rehabil Eng Date: 2019-08-14 Impact factor: 3.802
Authors: John H Hollman; Molly K Watkins; Angela C Imhoff; Carly E Braun; Kristen A Akervik; Debra K Ness Journal: Gait Posture Date: 2015-10-23 Impact factor: 2.840
Authors: Samuel T Nemanich; Ryan P Duncan; Leland E Dibble; James T Cavanaugh; Terry D Ellis; Matthew P Ford; Kenneth B Foreman; Gammon M Earhart Journal: Parkinsons Dis Date: 2013-06-05